• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

维拉帕米与苄普地尔治疗叙利亚仓鼠家族性心肌病的比较。

Comparison of verapamil and bepridil in the therapy of familiar cardiomyopathy of the Syrian hamster.

作者信息

Kunkel B, Hofmann U, Mutschler M

机构信息

Medizinische Poliklinik der Universität Erlangen, F.R.G.

出版信息

Z Kardiol. 1987;76 Suppl 3:159-63.

PMID:3501643
Abstract

The effect of bepridil compared to verapamil on the cardiomyopathic hamster (Strain Bio 8262) was evaluated. Bepridil (10 mg/kg) was injected twice daily for 15 and 30 days. Verapamil (10 mg/kg) was injected twice daily for 30 days. Control animals were treated with NaCl. After life-day 30, large infarct-like lesions predominantly located in the central portion of the left ventricular walls were observed, while single cell necrosis occurred only in a few cases. In peripheral muscles, the necrotizing process started even before life-day 30. In the skeletal muscles, small foci of cell necrosis were the predominant type of lesion. Myocardial calcium accumulation and cell necrosis could be completely prevented by verapamil and were not influenced by bepridil. Both drugs were ineffective in the skeletal muscles. The infarct-like lesions of the myocardium demonstrate that a vascular component is involved in the pathogenesis of necrosis, in addition to the inherited disturbance of calcium metabolism. The results demonstrate that not all drugs with calcium antagonistic potencies have identical cardioprotective effects in the cardiomyopathic hamster.

摘要

评估了苄普地尔与维拉帕米对心肌病仓鼠(Bio 8262品系)的作用。苄普地尔(10毫克/千克)每日注射两次,持续15天和30天。维拉帕米(10毫克/千克)每日注射两次,持续30天。对照动物用氯化钠治疗。在第30个生命日之后,观察到主要位于左心室壁中央部分的大片梗死样病变,而单细胞坏死仅在少数情况下发生。在周围肌肉中,坏死过程甚至在第30个生命日之前就开始了。在骨骼肌中,小的细胞坏死灶是主要的病变类型。维拉帕米可完全预防心肌钙积累和细胞坏死,而苄普地尔对此无影响。两种药物对骨骼肌均无效。心肌梗死样病变表明,除了遗传性钙代谢紊乱外,血管成分也参与了坏死的发病机制。结果表明,并非所有具有钙拮抗作用的药物在心肌病仓鼠中都具有相同的心脏保护作用。

相似文献

1
Comparison of verapamil and bepridil in the therapy of familiar cardiomyopathy of the Syrian hamster.维拉帕米与苄普地尔治疗叙利亚仓鼠家族性心肌病的比较。
Z Kardiol. 1987;76 Suppl 3:159-63.
2
Disturbed myocardial calcium metabolism: a possible pathogenetic factor in the hereditary cardiomyopathy of the Syrian hamster.心肌钙代谢紊乱:叙利亚仓鼠遗传性心肌病的一个可能致病因素。
Recent Adv Stud Cardiac Struct Metab. 1975;6:207-17.
3
Prevention of myocardial generation in hamsters with hereditary cardiomyopathy.预防遗传性心肌病仓鼠的心肌生成。
Recent Adv Stud Cardiac Struct Metab. 1975;6:219-29.
4
Verapamil preserves myocardial contractility in the hereditary cardiomyopathy of the Syrian hamster.维拉帕米可维持叙利亚仓鼠遗传性心肌病中的心肌收缩力。
Circ Res. 1982 Mar;50(3):405-12. doi: 10.1161/01.res.50.3.405.
5
Effect of the calcium antagonists bepridil (CERM-1978) and verapamil on Ca++-dependent slow action potentials in frog skeletal muscle.钙拮抗剂苄普地尔(CERM - 1978)和维拉帕米对蛙骨骼肌中钙依赖性慢动作电位的影响。
J Pharmacol Exp Ther. 1982 Jul;222(1):80-6.
6
Cardioprotective efficacy of verapamil and mibefradil in young UM-X7.1 cardiomyopathic hamsters.维拉帕米和米贝拉地尔对年轻UM-X7.1心肌病仓鼠的心脏保护作用
Cardiovasc Drugs Ther. 1999 Nov;13(6):525-30. doi: 10.1023/a:1007879704878.
7
Effect of magnesium pyridoxal 5-phosphate glutamate on the hamster cardiomyopathy.
Arzneimittelforschung. 1992 Mar;42(3):292-6.
8
Effect of trimetazidine and verapamil on the cardiomyopathic hamster myosin phenotype.曲美他嗪和维拉帕米对心肌病仓鼠肌球蛋白表型的影响。
Br J Pharmacol. 1998 Feb;123(4):611-6. doi: 10.1038/sj.bjp.0701643.
9
Effects of L-carnitine and verapamil on myocardial carnitine concentration and histopathology of Syrian hamster BIO 14.6.左旋肉碱和维拉帕米对叙利亚仓鼠BIO 14.6心肌肉碱浓度及组织病理学的影响
Cardiovasc Res. 1986 Aug;20(8):614-20. doi: 10.1093/cvr/20.8.614.
10
Cardiac collagen remodeling in the cardiomyopathic Syrian hamster and the effect of losartan.心肌病叙利亚仓鼠的心脏胶原重塑及氯沙坦的作用
J Mol Cell Cardiol. 1997 Jul;29(7):1837-50. doi: 10.1006/jmcc.1997.0420.